Pharmacological Management of Orofacial Pain

Drugs. 2023 Sep;83(14):1269-1292. doi: 10.1007/s40265-023-01927-z. Epub 2023 Aug 26.

Abstract

Orofacial pain is a category of complex disorders, including musculoskeletal, neuropathic and neurovascular disorders, that greatly affect the quality of life of the patient. These disorders are within the fields of dentistry and medicine and management can be challenging, requiring a referral to an orofacial pain specialist, essential for adequate evaluation, diagnosis, and care. Management is specific to the diagnosis and a treatment plan is developed with diverse pharmacological and non-pharmacological modalities. The pharmacological management of orofacial pain encompasses a vast array of medication classes and approaches. This includes anti-inflammatory drugs, muscle relaxants, anticonvulsants, antidepressants, and anesthetics. In addition, as adjunct therapy, different injections can be integrated into the management plan depending on the diagnosis and needs. These include trigger point injections, temporomandibular joint (TMJ) injections, and neurotoxin injections with botulinum toxin and nerve blocks. Multidisciplinary management is key for optimal care. New and safer therapeutic targets exclusively for the management of orofacial pain disorders are needed to offer better care for this patient population.

Publication types

  • Review

MeSH terms

  • Anticonvulsants / therapeutic use
  • Botulinum Toxins* / therapeutic use
  • Facial Pain / drug therapy
  • Humans
  • Nerve Block*
  • Quality of Life

Substances

  • Anticonvulsants
  • Botulinum Toxins